Warning: Trying to access array offset on value of type bool in /www/wwwroot/www.medtourcn.com/wp-content/themes/medical-directory/framework/theme/medicaldirectory-image.php on line 78
Warning: Trying to access array offset on value of type bool in /www/wwwroot/www.medtourcn.com/wp-content/themes/medical-directory/framework/theme/medicaldirectory-image.php on line 79
Meet Chinese Doctor. Xiaoyan Ke: Leading Expert in Hematology and Lymphoma Treatment
Meet Chinese Doctor. Xiaoyan Ke: Leading Expert in Hematology and Lymphoma Treatment
Global Healthcare
In the journey of treating hematologic malignancies, for patients in advanced stages with no standard clinical treatment options, seeking medical care abroad or through remote video consultations has become a pathway to new hope. Through these means, patients can connect with top international experts and gain access to new treatment plans and more options. Leading international specialists not only continuously achieve breakthroughs in treatment technologies but also provide personalized treatment recommendations based on the latest research. Next, we are proud to introduce a highly acclaimed and renowned expert in the fields of hematology and lymphoma from China—Professor Ke Xiaoyan.
### Expert Profile
**Professor Ke Xiaoyan** is the Chief Physician of the Hematology Department at Peking University Third Hospital and serves as the Lead Expert of the Adult Lymphoma Division at the GoBroad Medical (Hematology) Beijing Research Center. She is also the Deputy Director of the Hematology Department at Peking University Health Science Center. Additionally, she holds the position of Chief Consultant for the Adult Lymphoma Department at Beijing GoBroad-Boren Hospital, where she has trained numerous PhD students, establishing herself as one of China’s top experts in hematologic oncology.
Professor Ke is highly regarded within the Chinese medical community. She has served as the Chairperson of the Hematology Branch of the Chinese Female Physicians Association and currently holds key positions in several authoritative medical organizations. Her academic background and international reputation have earned her wide recognition in the field of hematologic malignancy treatment.
### Areas of Expertise
Professor Ke has extensive experience in the standardized treatment of lymphoma, targeted chemotherapy, and both autologous and allogeneic hematopoietic stem cell transplantation. She is at the forefront of international research in treating relapsed and refractory lymphomas through second-generation gene sequencing, targeted therapies, and CAR-T cell immunotherapy. Beyond her clinical expertise, she is a leading figure in the molecular diagnosis of malignant blood diseases and the monitoring of minimal residual disease.
### Research Contributions and International Reputation
Professor Ke has made remarkable achievements in scientific research as well. She has been the principal investigator in more than 70 international multicenter clinical trials and has published over 300 academic papers, including more than 30 influential SCI papers in top-tier international journals, focusing on cutting-edge research in lymphoma and hematologic malignancies. She has authored and contributed to more than 30 authoritative medical books and received over 40 national research grants, significantly advancing the field of hematology.
In addition to her research work, Professor Ke serves on the editorial boards of several medical journals, including as Deputy Editor-in-Chief of the **Journal of Leukemia & Lymphoma**. She is also a consulting expert for the Ministry of Health and a key member of the Central Health Consultation Committee. As a leading figure in international hematologic oncology research, her studies encompass the molecular mechanisms of lymphoma, immunotherapy, and stem cell transplantation, enhancing China’s standing in global academic research.
### Main Research Focuses
– Standardized treatment of lymphoma
– Molecular diagnosis of malignant blood diseases and monitoring of minimal residual disease
– Research on autologous peripheral blood stem cell transplantation for malignant blood diseases
– Non-myeloablative transplantation and CAR-T cell therapy for refractory relapsed malignant lymphoma
– Research on B7/CD28 signaling and T-cell immune tolerance mechanisms
– Study of the molecular mechanisms of tumor immunity
### Publications and Research Achievements
Professor Ke Xiaoyan has authored several authoritative books in the field of lymphoma, including **Lymphoma** and **Lymphoma Diagnosis and Treatment Manual**. Her key SCI papers include:
-
**Biological and Clinical Influences of NPM1 in AML Patients with DNMT3A Mutations**, *Cancer Management and Research*, 2018.
-
**Clinical and Biological Implications of IDH1/2 in AML with DNMT3A Mutation**, *Cancer Management and Research*, 2018.
-
**High PD-L1 Expression Predicts Poor Prognosis in Diffuse Large B-cell Lymphoma**, *Annals of Hematology*, 2018.
-
**Molecular Predictors of Post-transplant Survival in Acute Myeloid Leukemia**, *Blood Cancer Journal*, 2017.
-
**High Expression of CPNE3 Predicts Adverse Prognosis in AML**, *Cancer Science*, 2017.
-
**High Expression of ETS2 Predicts Poor Prognosis in AML**, *Journal of Translational Medicine*, 2017.
-
**A Minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 Contributes to Leukemogenesis in t(8;21) AML**, *International Journal of Cancer*, 2017.
### Online Consultation and Appointment Information
Professor Ke currently offers online video consultation services. Patients can make appointments through the following methods:
WhatsApp: Https://wa.me/+8613717959070
Wechat：doctors0152
Email: doctor.huang@globecancer.com
#Hematology #LymphomaTreatment #AdvancedCancerCare #InternationalConsultation #CAR_TTherapy #PersonalizedMedicine #ProfessorKeXiaoyan #StemCellTransplantation #CancerResearch #GlobalHealthcare
Warning: Trying to access array offset on value of type bool in /www/wwwroot/www.medtourcn.com/wp-content/themes/medical-directory/framework/theme/medicaldirectory-image.php on line 78
Warning: Trying to access array offset on value of type bool in /www/wwwroot/www.medtourcn.com/wp-content/themes/medical-directory/framework/theme/medicaldirectory-image.php on line 79
Three Major Reasons and Process to Choose Medical Treatment in China
Three Major Reasons and Process to Choose Medical Treatment in China
Medical Treatment
### High-Quality Medical Care
In recent years, China’s medical technology has made significant strides, achieving a strong and leading position globally. China boasts advanced medical technologies and equipment, with many hospitals offering world-class diagnostic and treatment capabilities. Patients who travel to China for medical care consistently give high praise for the quality of medical services they receive.
### Convenience of Traveling to China
China offers convenient transportation options with many countries, including direct flights and various other travel modes. The time and cost required to travel to China are relatively low, making it a convenient medical destination. Recently, China has introduced a 144-hour visa-free transit policy, further enhancing the possibilities for medical travel.
### Culture and Sense of Security
China is widely recognized for its safety, and its close cultural exchanges with other countries, especially within Asia, provide a sense of comfort and familiarity for patients. Additionally, English is widely spoken in many Chinese cities.
## Process for Seeking Medical Treatment in China
Medical Treatment
### Preparing for the Trip
Preparation for medical treatment in China involves several steps, including contacting medical institutions and obtaining a medical visa. It is advisable to seek assistance from international medical coordination agencies. When consulting, prepare a description of your condition, past medical records (such as reports and images), your preferred hospital, budget, and expected timeframe.
### Connecting with Medical Institutions
Coordinate with Chinese medical institutions through international medical agencies to confirm whether treatment will be accepted and to obtain detailed information about the treatment plan, timeline, and costs. Adjust your stay plans based on the information provided.
– Costs: In some cases, consulting medical institutions may incur fees.
– Time: It may take several days to receive a response from the medical institution, and processing visas might take one to two weeks, so allow sufficient time.
### Prepayment of Estimated Treatment Costs
Treatment costs are typically prepaid through international medical agencies. To ease financial burden, transfer the estimated treatment costs to the coordination agency before traveling. If actual costs are lower than estimated, the balance will be refunded; if higher, the difference must be paid during treatment. Confirm refund and additional payment methods in advance.
### Obtaining a Visa
A visa is required for travel to China. If you do not have a visa, consult an international medical coordination agency for assistance in obtaining a medical visa. If you already have a visa, confirm its validity and allowed stay duration. Recently, China has reinstated the 144-hour visa-free transit for citizens of many countries. For international medical services, hospitals or coordination agencies can assist with longer stays.
### Traveling to China and Receiving Treatment
International medical agencies can arrange transportation and other necessary assistance. During hospitalization, both the coordination agency and the hospital will provide required services, so limit the number of accompanying persons.
### Settlement of Medical Expenses
The estimated treatment costs prepaid before traveling will be settled based on actual expenses after treatment. Direct payment to medical institutions is usually unnecessary. Costs include hospital examinations, treatment fees, translation services, and other related expenses.
### Follow-Up After Returning Home
Continue follow-up care with local doctors after returning home. Regularly send updates on your condition and examination results to the international medical coordination agency for confirmation by the Chinese hospital.
## Frequently Asked Questions
### What are the advantages of receiving treatment in China?
China has highly professional medical staff and offers advanced medical services with excellent collaboration.
### Testimonials from Patients Treated in China:
– Domestic doctors did not recommend surgery, but I heard Chinese hospitals had experience, so I considered treatment in China.
– Chinese hospitals not only provided guidance from pharmacists and dietary advice from nutritionists but also offered post-discharge life suggestions, which I found very satisfactory.
### Can patients with illnesses seek treatment in China?
Many patients have successfully received treatment in China. Due to convenient transportation and lower costs, China is an ideal medical destination.
### Can I receive treatment in China without speaking Chinese?
International medical coordination agencies offer language support and other assistance based on patient needs, including arranging airport pickups, assisting with hotel check-ins, and hospital transfers to ensure smooth medical care.
### How long does it take to prepare for travel to China, including obtaining a medical visa?
It typically takes 1-2 months from providing medical information for hospital assessment to obtaining a medical visa. It is advisable to arrange related preparations in advance.
If you would like to learn more about seeking medical treatment in China, please contact us @advanced medicine in china
WhatsApp: +8613717959070
Email: doctor.huang@globecancer.com
#MedicalTourism #ChinaHealthcare #AdvancedMedicalCare #QualityHealthcare #ConvenientTravel #CulturalComfort #SafeTravel #MedicalVisa #InternationalPatients #WorldClassMedicine #HealthcareJourney #PatientExperience
Warning: Trying to access array offset on value of type bool in /www/wwwroot/www.medtourcn.com/wp-content/themes/medical-directory/framework/theme/medicaldirectory-image.php on line 78
Warning: Trying to access array offset on value of type bool in /www/wwwroot/www.medtourcn.com/wp-content/themes/medical-directory/framework/theme/medicaldirectory-image.php on line 79
Breakthrough in mRNA Cancer Vaccine! Chinese Medical Team Brings New Hope to Advanced Cancer Patients Resistant to Traditional Treatments
Breakthrough in mRNA Cancer Vaccine! Chinese Medical Team Brings New Hope to Advanced Cancer Patients Resistant to Traditional Treatments
Cancer Vaccine